Literature DB >> 16503878

Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.

Ai Harashima1, Yasuhiko Yamamoto, Chunmei Cheng, Koichi Tsuneyama, Khin Mar Myint, Akihiko Takeuchi, Kazunobu Yoshimura, Hui Li, Takuo Watanabe, Shin Takasawa, Hiroshi Okamoto, Hideto Yonekura, Hiroshi Yamamoto.   

Abstract

The cell-surface RAGE [receptor for AGE (advanced glycation end-products)] is associated with the development of diabetic vascular complications, neurodegenerative disorders and inflammation. Recently, we isolated a human RAGE splice variant, which can work as a decoy receptor for RAGE ligands, and named it esRAGE (endogenous secretory RAGE). In the present study, we have isolated the murine equivalent of esRAGE from brain polysomal poly(A)+ (polyadenylated) RNA by RT (reverse transcription)-PCR cloning. The mRNA was generated by alternative splicing, and it encoded a 334-amino-acid protein with a signal sequence, but lacking the transmembrane domain. A transfection experiment revealed that the mRNA was actually translated as deduced to yield the secretory protein working as a decoy in AGE-induced NF-kappaB (nuclear factor kappaB) activation. RT-PCR and immunoblotting detected esRAGE mRNA and protein in the brain, lung, kidney and small intestine of wild-type mice, but not of RAGE-null mice. The esRAGE expression was increased in the kidney of diabetic wild-type mice. The present study has thus provided an animal orthologue of esRAGE for clarification of its roles in health and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503878      PMCID: PMC1450004          DOI: 10.1042/BJ20051573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.

Authors:  A M Schmidt; D M Stern
Journal:  Trends Endocrinol Metab       Date:  2000-11       Impact factor: 12.015

2.  Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

Authors:  Hideto Yonekura; Yasuhiko Yamamoto; Shigeru Sakurai; Ralica G Petrova; Md Joynal Abedin; Hui Li; Kiyoshi Yasui; Masayoshi Takeuchi; Zenji Makita; Shin Takasawa; Hiroshi Okamoto; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

3.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Authors:  M Neeper; A M Schmidt; J Brett; S D Yan; F Wang; Y C Pan; K Elliston; D Stern; A Shaw
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

Authors:  Kazuhiro Abeyama; David M Stern; Yuji Ito; Ko-ichi Kawahara; Yasushi Yoshimoto; Motoyuki Tanaka; Tomonori Uchimura; Nobuo Ida; Yoshiaki Yamazaki; Shingo Yamada; Yasuhiko Yamamoto; Hiroshi Yamamoto; Satoshi Iino; Noboru Taniguchi; Ikuro Maruyama
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

6.  Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs.

Authors:  Chunmei Cheng; Koichi Tsuneyama; Rieko Kominami; Harumichi Shinohara; Shigeru Sakurai; Hideto Yonekura; Takuo Watanabe; Yasuo Takano; Hiroshi Yamamoto; Yasuhiko Yamamoto
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

Review 7.  Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

Authors:  Thoralf Wendt; Nozomu Tanji; Jiancheng Guo; Barry I Hudson; Angelika Bierhaus; Ravichandran Ramasamy; Bernd Arnold; Peter P Nawroth; Shi Fang Yan; Vivette D'Agati; Ann Marie Schmidt
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

8.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Authors:  Y Yamamoto; I Kato; T Doi; H Yonekura; S Ohashi; M Takeuchi; T Watanabe; S Yamagishi; S Sakurai; S Takasawa; H Okamoto; H Yamamoto
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

9.  Development of an ELISA for esRAGE and its application to type 1 diabetic patients.

Authors:  Shigeru Sakurai; Yasuhiko Yamamoto; Hironori Tamei; Hirokazu Matsuki; Ken-Ichi Obata; Li Hui; Junnosuke Miura; Mari Osawa; Yasuko Uchigata; Yasuhiko Iwamoto; Takuo Watanabe; Hideto Yonekura; Hiroshi Yamamoto
Journal:  Diabetes Res Clin Pract       Date:  2006-02-20       Impact factor: 5.602

10.  The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.

Authors:  Triantafyllos Chavakis; Angelika Bierhaus; Nadia Al-Fakhri; Darius Schneider; Steffen Witte; Thomas Linn; Mariko Nagashima; John Morser; Bernd Arnold; Klaus T Preissner; Peter P Nawroth
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  17 in total

1.  Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling.

Authors:  Hanbyeol Lee; Jeong-Ran Park; Woo Jin Kim; Isaac K Sundar; Irfan Rahman; Sung-Min Park; Se-Ran Yang
Journal:  FASEB J       Date:  2017-02-01       Impact factor: 5.191

2.  Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.

Authors:  Lin Lu; Wen-Hui Peng; Wei Wang; Ling-Jie Wang; Qiu-Jing Chen; Wei-Feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

3.  Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia.

Authors:  Rosaria Greco; Diana Amantea; Antonina Stefania Mangione; Francesco Petrelli; Rocco Gentile; Giuseppe Nappi; Fabio Blandini; M Tiziana Corasaniti; Cristina Tassorelli
Journal:  Neurochem Res       Date:  2012-04-19       Impact factor: 3.996

Review 4.  Dangers within: DAMP responses to damage and cell death in kidney disease.

Authors:  Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

Review 5.  All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

Authors:  Elizabeth A Oczypok; Timothy N Perkins; Tim D Oury
Journal:  Paediatr Respir Rev       Date:  2017-03-18       Impact factor: 2.726

6.  Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.

Authors:  Anastasia Z Kalea; Nina Reiniger; Hojin Yang; Maria Arriero; Ann Marie Schmidt; Barry I Hudson
Journal:  FASEB J       Date:  2009-01-22       Impact factor: 5.191

Review 7.  RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

Authors:  Louis J Sparvero; Denise Asafu-Adjei; Rui Kang; Daolin Tang; Neilay Amin; Jaehyun Im; Ronnye Rutledge; Brenda Lin; Andrew A Amoscato; Herbert J Zeh; Michael T Lotze
Journal:  J Transl Med       Date:  2009-03-17       Impact factor: 5.531

8.  Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.

Authors:  Joel Jules; Dony Maiguel; Barry I Hudson
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals.

Authors:  Raquel López-Díez; Alberto Rastrojo; Olatz Villate; Begoña Aguado
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

Review 10.  Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.

Authors:  Nontaphat Leerach; Ai Harashima; Seiichi Munesue; Kumi Kimura; Yu Oshima; Hisanori Goto; Hiroshi Yamamoto; Haruhiro Higashida; Yasuhiko Yamamoto
Journal:  Glycoconj J       Date:  2020-10-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.